Verve Health, an Indianapolis-based company that provides wellness and health clinics to employers, is pitching a new option—integrative medicine. If plans are successful, it could add more than 100 workers in the next year.
Takeda Pharmaceutical Co. executives have agreed to pay more than $2.3 billion to resolve lawsuits accusing the company of hiding its Actos diabetes medicine’s cancer risks, three people familiar with the accord said.
Indiana University Health announced Friday that the $1 billion project consolidating its downtown hospitals will take five to seven years to complete, during which time University Hospital will remain open to patients just as it is now.
Four residents of the town of Princeton sued to revoke the university's tax exemption, in part because it shares royalties with faculty, mostly from a patent that Indianapolis-based Eli Lilly and Co. turned into the cancer drug Alimta.
After 15 years on the air, "Sound Medicine" will broadcast its last new episode on April 26. The Indiana University School of Medicine, the show's primary funder, wants to change the direction of its marketing.
New research from the Mayo Clinic is bringing back a long-running debate over whether drug companies like Eli Lilly and Biogen are focusing on the right target in developing therapies to treat the disease.